Sayville Injectafer Lawsuit Lawyer

Our law firm is currently handling lawsuits on behalf of individuals who have taken Injectafer for the treatment of iron deficiency anemia in adults. Lawsuits against manufacturers of Injectafer claim that the medication leads to unusually low levels of phosphorus, known as hypophosphatemia (HPP).

What Do We Know About Injectafer Lawsuits?

When the body lacks sufficient iron, an individual can develop anemia. Injectafer can be administered via infusion to treat anemia in adults. Patients who cannot tolerate oral iron supplements can receive iron intravenously from a healthcare provider.

Several recent studies have shown that patients treated with Injectafer were more likely to develop HPP and to show symptoms of severe HPP than those treated with alternative iron infusion. Despite studies linking HPP and Injectafer, the manufacturer has failed to provide adequate warnings addressing all the risks of Injectafer.

Recent lawsuits have claimed that Injectafer may have serious and potentially lethal consequences. In Philadelphia, plaintiffs Teresa J. Edwards and Barbara Kessler allege that Injectafer caused them to develop HPP. After 10 infusions, Ms. Edwards suffered from severe muscle fatigue and pain. Ms. Kessler had several infusions and reported bone pain, severe weakness, and shortness of breath.

Injectafer Injuries

Injectafer significantly lowers the amount of phosphorus in the body. This can lead to HPP, which can cause fatigue, muscle weakness, and cognitive symptoms. If HPP is not treated, more severe complications can result. Patients have experienced seizures, respiratory failure, heart conditions, and rhabdomyolysis (a condition in which the impaired muscle discharges proteins and electrolytes into the blood). Severe HPP may lead to coma and death.

Can I Recover Compensation for My Injuries in an Injectafer Lawsuit?

If you or a loved one has been injured by Injectafer, you may recover compensation for any or all of the following:

  • Past and future medical expenses;
  • Past and future pain and suffering;
  • Loss of wages; and
  • Other economic losses related to your injury.

How Our Law Firm Can Help You

The Lake Law Firm was founded by Edward J. Lake, Esq., a personal injury lawyer for over 25 years. Our dedicated team of attorneys is committed to seeking justice on behalf of those who have suffered injury or death due to the negligence of others. Our experienced attorneys handle many different types of pharmaceutical drugs, medical devices, and other defective products. The lawyers in our firm have helped collect millions of dollars for their clients. The Lake Law Firm will advocate for you and your rights. Please contact us for a free confidential case evaluation at (888) 274-0139 or submit an inquiry on this page.

Injectafer Studies

Studies indicate that the incidence of HPP is significantly higher in patients being treated with Injectafer than those taking alternative iron supplements. In February 2020, a study found that 73-74% of patients routinely taking Injectafer developed HPP. In contrast, only 8% of patients taking the iron infusion drug, Monoferric, showed symptoms of HPP. In patients treated with Injectafer, 11.3% developed severe HPP while those treated with Monoferric showed no signs of severe HPP. An earlier study in 2018 showed that more than half of patients treated with Injectafer had severe HPP while less than 1% of patients treated with an alternative medication, Feraheme, exhibited symptoms of severe HPP.

Liability Law and Injectafer Cases

  • Patients may have a product liability claim against the manufacturer of Injectafer for failure to warn of the risks associated with the medication.
  • The manufacturer failed to adequately warn patients and physicians despite being aware that Injectafer could cause severe HPP.
  • The drug label did not warn of severe HPP and did not accurately address the risks of low phosphorus levels.